It approves tissue-based NGS companion diagnostic for Takeda's targeted therapy for NSCLC patients with EGFR Exon20 insertion mutations
GMP certification helps enable biotechnology customers to accelerate accessibility of new RNA-based therapies for patients
Julie is recognized as a highly engaging multi-cultural leader skilled in fluidly partnering with cross-functional teams to deliver results.
A total of 889 M&A deals were announced in the medical devices sector in 2022 worth $93 billion
Cell sorting technology supports researchers advancing new therapies
It allows users to generate cell lines suitable for clinical development without their own starter cells, vectors or prior experience in the field.
With this expansion, the Grand Island site provides redundant capacity to support global supply of media and further extends the site’s capabilities to produce the high-quality technology and materials needed for the development and commercial manufacturing of vaccines and biologic therapies
Sam Samad will be departing Illumina on July 8, 2022, after serving as CFO for more than five years.
The $44 million facility is part of Thermo Fisher's $650 million multi-year investment, announced last year, to help ensure flexible, scalable and reliable bioprocessing production capacity exists for critical materials used in developing new and existing biologics and vaccines, including for COVID-19
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)